Antidote’s approach to driving diversity, equity, and inclusion in patient recruitment [whitepaper]

At Antidote, we believe that all members of society should be equally represented — especially when it comes to medical research. Historically, racial and ethnic minorities have been under-represented in the clinical trial space, and continue to face challenges when trying to access healthcare today.

As a digital patient engagement company in the clinical trials space, our mission is to connect patients to clinical research to drive medical progress forward. We believe that all individuals should have the opportunity to discover and participate in clinical trials, which is why we are committed to putting diversity, equity, and inclusion (DEI) at the center of everything we do.

In this whitepaper, we’re providing an overview of the current state of DEI in clinical trials, the need for change across the industry, and how Antidote has committed to being a vanguard in this important space. By clearly defining our DEI tenets and making improvements to our product, communications, and internal operations with this framework in mind, we are able to be part of the solution. Download the whitepaper today to learn more about our efforts.